Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of SNAP25 mRNA | affects expression | 16483693
|
D000643 |
Ammonium Chloride |
Ammonium Chloride results in decreased expression of SNAP25 protein | decreases expression | 16483693
|
D017638 |
Asbestos, Crocidolite |
Asbestos, Crocidolite results in decreased expression of SNAP25 mRNA | decreases expression | 18687144
|
C053541 |
bicalutamide |
bicalutamide results in increased expression of SNAP25 mRNA | increases expression | 15790403
|
D019274 |
Botulinum Toxins, Type A |
Botulinum Toxins, Type A results in increased cleavage of SNAP25 protein | increases cleavage | 17666428
|
C096324 |
botulinum toxin type C |
botulinum toxin type C results in increased cleavage of SNAP25 protein | increases cleavage | 17666428
|
D002713 |
Chlorine |
[Ozone co-treated with Chlorine] results in increased expression of SNAP25 mRNA | affects cotreatment|increases expression | 18636392
|
D003024 |
Clozapine |
SNAP25 gene SNP affects the susceptibility to Clozapine | affects response to substance | 15823421
|
D003024 |
Clozapine |
Clozapine results in increased expression of SNAP25 mRNA | increases expression | 15860345
|
C009160 |
cyclonite |
cyclonite results in increased expression of SNAP25 mRNA | increases expression | 19417177
|
D005419 |
Flavonoids |
Flavonoids results in increased expression of SNAP25 mRNA | increases expression | 18035473
|
D006220 |
Haloperidol |
SNAP25 gene SNP affects the susceptibility to Haloperidol | affects response to substance | 15823421
|
D006220 |
Haloperidol |
Haloperidol affects the expression of SNAP25 mRNA | affects expression | 15860345
|
C057416 |
KT 5720 |
KT 5720 inhibits the reaction [PRKACA protein results in increased phosphorylation of SNAP25 protein] | decreases reaction|increases phosphorylation | 14766180
|
C008493 |
methylselenic acid |
methylselenic acid results in increased expression of SNAP25 mRNA | increases expression | 18548127
|
C076029 |
olanzapine |
SNAP25 gene SNP affects the susceptibility to olanzapine | affects response to substance | 15823421
|
D010126 |
Ozone |
[Ozone co-treated with Chlorine] results in increased expression of SNAP25 mRNA | affects cotreatment|increases expression | 18636392
|
D018967 |
Risperidone |
SNAP25 gene SNP affects the susceptibility to Risperidone | affects response to substance | 15823421
|
D012643 |
Selenium |
[Selenium co-treated with Vitamin E] results in decreased expression of SNAP25 mRNA | affects cotreatment|decreases expression | 19244175
|
D012643 |
Selenium |
Selenium results in decreased expression of SNAP25 mRNA | decreases expression | 19244175
|
D014810 |
Vitamin E |
[Selenium co-treated with Vitamin E] results in decreased expression of SNAP25 mRNA | affects cotreatment|decreases expression | 19244175
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.55 | 18287403 |
MESH:D055371 |
Acute Lung Injury |
|
Chlorine |
4.31 | 20601635 |
MESH:D000380 |
Agranulocytosis |
|
Clozapine |
5.04 | 14617031 12649775 16160616 |
MESH:D000544 |
Alzheimer Disease |
|
Ozone |
2.43 | 15513908 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Ozone |
2.55 | 15570426 |
MESH:D020817 |
Asperger Syndrome |
|
Risperidone |
5.49 | 16401163 |
MESH:D001249 |
Asthma |
|
Ozone |
2.63 | 17854713 16373670 |
MESH:D001289 |
Attention Deficit Disorder with Hyperactivity |
|
Risperidone |
4.78 | 18349709 |
MESH:D001321 |
Autistic Disorder |
|
Haloperidol |
2.66 | 18080171 19368416 |
MESH:D001321 |
Autistic Disorder |
|
olanzapine |
2.66 | 18685284 17069543 |
MESH:D001321 |
Autistic Disorder |
|
Risperidone |
2.66 | 15994720 16379507 19154706 18278980 18775368 19368416 19232924 19013209 15930063 16948927 16601648 17069546 16730335 16239862 17929164 18349709 18080171 18026891 17019624 15543515 15492353 |
MESH:D001714 |
Bipolar Disorder |
marker/mechanism |
|
| 14708030 |
MESH:D001714 |
Bipolar Disorder |
|
Risperidone |
4.51 | 19154706 18278980 |
MESH:D016535 |
Bronchial Hyperreactivity |
|
Ozone |
3.66 | 18315731 16777450 18417511 17626835 14754758 19059883 15516495 |
MESH:D002012 |
Bruxism |
|
Botulinum Toxins, Type A |
7.91 | 16703933 |
MESH:D002100 |
Cachexia |
|
Ozone |
4.73 | 16183385 |
MESH:D002252 |
Carbon Tetrachloride Poisoning |
|
Vitamin E |
3.92 | 16050911 |
MESH:D002375 |
Catalepsy |
|
Haloperidol |
4.90 | 1977408 15215559 |
MESH:D002389 |
Catatonia |
|
olanzapine |
6.25 | 16772815 18071103 |
MESH:D003072 |
Cognition Disorders |
|
Clozapine |
4.95 | 17123785 |
MESH:D003092 |
Colitis |
|
Selenium |
3.77 | 17936198 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Vitamin E |
1.91 | 19769572 |
MESH:D003556 |
Cystitis |
|
Botulinum Toxins, Type A |
7.02 | 12599022 |
MESH:D016757 |
Death, Sudden, Cardiac |
|
Haloperidol |
11.40 | 20210726 |
MESH:D016757 |
Death, Sudden, Cardiac |
|
Risperidone |
11.40 | 20210726 |
MESH:D003704 |
Dementia |
|
Haloperidol |
10.49 | 11575062 |
MESH:D003704 |
Dementia |
|
Risperidone |
10.49 | 11575062 |
MESH:D003866 |
Depressive Disorder |
marker/mechanism |
|
| 14708030 |
MESH:D002658 |
Developmental Disabilities |
|
olanzapine |
4.68 | 17069543 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Clozapine |
2.97 | 16402076 |
MESH:D006970 |
Disorders of Excessive Somnolence |
|
Clozapine |
14.45 | 15331141 |
MESH:D006970 |
Disorders of Excessive Somnolence |
|
Risperidone |
14.45 | 16379507 |
MESH:D053207 |
Diurnal Enuresis |
|
Risperidone |
6.68 | 17822346 |
MESH:D004314 |
Down Syndrome |
|
Risperidone |
5.04 | 18349709 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Selenium |
2.17 | 15131321 |
MESH:D050171 |
Dyslipidemias |
|
Clozapine |
4.17 | 16402076 |
MESH:D004417 |
Dyspnea |
|
Chlorine |
4.62 | 20016425 |
MESH:C538011 |
Eales disease |
|
Vitamin E |
4.70 | 9068938 |
MESH:D005739 |
Gas Poisoning |
|
Chlorine |
5.01 | 20016425 |
MESH:D006330 |
Heart Defects, Congenital |
|
Vitamin E |
2.98 | 16080930 |
MESH:D006333 |
Heart Failure |
|
Selenium |
3.06 | 17162251 |
MESH:D006548 |
Hernia, Diaphragmatic |
|
Vitamin E |
2.69 | 16863852 16490937 |
MESH:D019584 |
Hot Flashes |
|
Vitamin E |
3.97 | 14716179 |
MESH:D006943 |
Hyperglycemia |
|
Risperidone |
5.14 | 18278980 |
MESH:D006948 |
Hyperkinesis |
|
Clozapine |
4.90 | 16046005 |
MESH:D006963 |
Hyperphagia |
|
olanzapine |
6.22 | 17933447 |
MESH:D007249 |
Inflammation |
|
Flavonoids |
2.64 | 17296493 |
MESH:D007251 |
Influenza, Human |
|
Selenium |
10.96 | 16624496 |
MESH:D007251 |
Influenza, Human |
|
Vitamin E |
10.96 | 16624496 |
MESH:D007674 |
Kidney Diseases |
|
Vitamin E |
2.79 | 12488133 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Selenium |
3.87 | 16518626 |
MESH:D008064 |
Lipidoses |
|
Clozapine |
3.94 | 17567588 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Vitamin E |
1.90 | 16169303 |
MESH:D008133 |
Long QT Syndrome |
|
olanzapine |
4.71 | 20210726 |
MESH:D008171 |
Lung Diseases |
|
Ozone |
7.47 | 8266340 19066396 |
MESH:D008171 |
Lung Diseases |
|
Vitamin E |
7.47 | 16863852 |
MESH:D055370 |
Lung Injury |
|
Asbestos, Crocidolite |
9.20 | 17365036 |
MESH:D055370 |
Lung Injury |
|
Ozone |
9.20 | 20417186 |
MESH:D008175 |
Lung Neoplasms |
|
Ozone |
2.61 | 8597069 7614698 |
MESH:D008175 |
Lung Neoplasms |
|
Vitamin E |
2.61 | 11062179 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Selenium |
2.75 | 15318939 |
MESH:D001523 |
Mental Disorders |
|
Clozapine |
18.81 | 16856516 |
MESH:D001523 |
Mental Disorders |
|
Haloperidol |
18.81 | 16856516 |
MESH:D001523 |
Mental Disorders |
|
olanzapine |
18.81 | 16856516 |
MESH:D001523 |
Mental Disorders |
|
Risperidone |
18.81 | 16856516 16596465 |
MESH:D008607 |
Mental Retardation |
|
Risperidone |
4.10 | 18349709 |
MESH:D008654 |
Mesothelioma |
|
Asbestos, Crocidolite |
6.31 | 16966607 16166281 18303189 |
MESH:D008654 |
Mesothelioma |
|
Selenium |
6.31 | 15107826 |
MESH:D008659 |
Metabolic Diseases |
|
olanzapine |
5.37 | 19142110 |
MESH:D024821 |
Metabolic Syndrome X |
|
Clozapine |
10.12 | 19142101 |
MESH:D024821 |
Metabolic Syndrome X |
|
Risperidone |
10.12 | 19142101 |
MESH:D008679 |
Metaplasia |
|
Ozone |
5.11 | 10496685 |
MESH:D019964 |
Mood Disorders |
|
Risperidone |
5.82 | 17019624 |
MESH:D053206 |
Nocturnal Enuresis |
|
Risperidone |
6.33 | 17822346 |
MESH:D009765 |
Obesity |
|
Clozapine |
5.38 | 19142110 18515891 |
MESH:D009765 |
Obesity |
|
olanzapine |
5.38 | 18515891 |
MESH:D010538 |
Peritonitis |
|
Ozone |
4.12 | 16369182 |
MESH:D010954 |
Plasmacytoma |
|
Selenium |
4.89 | 15087411 |
MESH:D010995 |
Pleural Diseases |
|
Asbestos, Crocidolite |
4.88 | 10923243 |
MESH:D011014 |
Pneumonia |
|
Ozone |
4.39 | 18007984 18929643 18381685 |
MESH:D011471 |
Prostatic Neoplasms |
|
bicalutamide |
2.82 | 19240160 15638997 17914592 18487222 19011039 |
MESH:D011471 |
Prostatic Neoplasms |
|
methylselenic acid |
2.82 | 16205645 |
MESH:D011471 |
Prostatic Neoplasms |
|
Vitamin E |
2.82 | 15084515 |
MESH:D011595 |
Psychomotor Agitation |
|
Haloperidol |
11.77 | 11575062 |
MESH:D011595 |
Psychomotor Agitation |
|
olanzapine |
11.77 | 18685284 |
MESH:D011618 |
Psychotic Disorders |
marker/mechanism |
|
| 14708030 |
MESH:D011618 |
Psychotic Disorders |
|
Clozapine |
9.11 | 15331141 |
MESH:D011618 |
Psychotic Disorders |
|
Haloperidol |
9.11 | 11575062 |
MESH:D011658 |
Pulmonary Fibrosis |
|
Asbestos, Crocidolite |
3.02 | 15814490 17365031 17322281 17975199 |
MESH:D012120 |
Respiration Disorders |
|
Chlorine |
5.21 | 18579056 |
MESH:D012559 |
Schizophrenia |
|
Clozapine |
8.08 | 20580759 17123785 11151749 18855531 20107430 20452607 17726453 20521326 18806925 19369910 16141801 11763009 17667964 20168265 20521320 |
MESH:D012559 |
Schizophrenia |
|
Haloperidol |
8.08 | 20107430 19369910 18513383 1830565 |
MESH:D012559 |
Schizophrenia |
|
olanzapine |
8.08 | 20107430 20521326 17726453 |
MESH:D012559 |
Schizophrenia |
|
Risperidone |
8.08 | 20107430 18278980 19154706 |
MESH:D012640 |
Seizures |
|
cyclonite |
4.52 | 19417177 |
MESH:D012871 |
Skin Diseases |
|
Vitamin E |
2.44 | 18709164 |
MESH:D012893 |
Sleep Disorders |
|
Risperidone |
5.50 | 18278980 |
MESH:D020521 |
Stroke |
|
Vitamin E |
3.50 | 16517955 |
MESH:D017180 |
Tachycardia, Ventricular |
|
Haloperidol |
17.58 | 20210726 |
MESH:D017180 |
Tachycardia, Ventricular |
|
olanzapine |
17.58 | 20210726 |
MESH:D017180 |
Tachycardia, Ventricular |
|
Risperidone |
17.58 | 20210726 |
MESH:D005879 |
Tourette Syndrome |
|
Risperidone |
5.93 | 19154706 |
MESH:D015430 |
Weight Gain |
|
Clozapine |
16.53 | 20107430 20521320 16141801 16402076 17502770 20564506 |
MESH:D015430 |
Weight Gain |
|
olanzapine |
16.53 | 20107430 17933447 19434072 |
MESH:D015430 |
Weight Gain |
|
Risperidone |
16.53 | 16379507 20564506 |
MESH:D015431 |
Weight Loss |
|
Clozapine |
5.07 | 17933447 |